Skip to Main content Skip to Navigation
Journal articles

Successful treatment of severe anti-p200 pemphigoid in a heart transplant recipient with a single cycle of rituximab

Abstract : Anti-p200 pemphigoid is a rare autoimmune subepidermal blistering disease, first described in 1996.1 This disorder was initially considered as a more benign condition compared with bullous pemphigoid and epidermolysis bullosa acquisita, but in a recent series of patients, heterogeneous clinical presentations have been described, including cases with a more severe course than previously reported.2 We describe a case with a highly active disease in a heart transplant patient who experienced a dramatic and complete remission after 1 cycle of rituximab.
Complete list of metadatas

Cited literature [9 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01518892
Contributor : Laurent Jonchère <>
Submitted on : Thursday, May 3, 2018 - 2:52:38 PM
Last modification on : Thursday, June 18, 2020 - 9:29:18 AM
Long-term archiving on: : Monday, September 24, 2018 - 7:08:42 PM

File

Successful treatment of severe...
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution - NoDerivatives 4.0 International License

Identifiers

Citation

Lisa Rousseau, Catherine Droitcourt, Nolwenn Ropars, Bernard Lelong, Clémence Saillard, et al.. Successful treatment of severe anti-p200 pemphigoid in a heart transplant recipient with a single cycle of rituximab. JAAD Case reports, Elsevier, 2017, 3 (3), pp.175-177. ⟨10.1016/j.jdcr.2017.01.028⟩. ⟨hal-01518892⟩

Share

Metrics

Record views

511

Files downloads

194